hematologic malignanciesimmunotherapy
By The ASCO Post Staff / Quick Chats
hematologic malignancies
By The ASCO Post Staff / NCCN 2019 Annual Congress: Hematologic Malignancies
Andrew D. Zelenetz, MD, PhD, of Memorial Sloan Kettering Cancer Center, discusses the nature of biologic molecules and their importance in future therapeutic innovation.